Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin PK in Patients With Thermal Injury
NCT02241941Phase 4Withdrawn
- Sponsor
- University of Zurich
- Start
- Sep 2014
- Primary completion
- Oct 2016
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in burn injury, sponsored by University of Zurich. Planned start Sep 2014; status: withdrawn.
02
Drugs
daptomycin
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT02241941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241941.